You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

Article metrics

Article menu
XML
Cardiovascular and metabolic risk
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial

 

Online download statistics by month:

Online download statistics by month: September 2021 to March 2024

AbstractFullPdf
Sep 2021507505141
Oct 202126125682
Nov 202116715976
Dec 202110710638
Jan 2022777739
Feb 2022514859
Mar 2022515128
Apr 2022565534
May 2022666539
Jun 2022545232
Jul 2022696521
Aug 2022585027
Sep 2022595826
Oct 2022606135
Nov 2022685725
Dec 2022443824
Jan 2023524732
Feb 2023535518
Mar 2023303018
Apr 2023474439
May 2023403528
Jul 2023413619
Aug 2023444428
Sep 2023464427
Oct 2023434117
Nov 2023807821
Dec 20231109326
Jan 202410885305
Feb 2024826534
Mar 2024636040
Total259424601378